BCBP vs HYI
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
BCBP exhibits weak financial health with a Piotroski F-Score of 4/9, indicating borderline stability, and lacks an Altman Z-Score to confirm safety from distress. The stock trades at a significant premium to its Graham Number of $4.79, currently priced at $7.86, despite deteriorating fundamentals including negative earnings and revenue growth. Profitability metrics like ROE (0.86%) and ROA (0.08%) are extremely weak, while the dividend is unsustainable with a payout ratio exceeding 1000%. Although analysts recommend a 'buy' with a $9.50 target, the company's track record of earnings misses and declining performance raises serious concerns.
The deterministic health profile is critical, highlighted by a Piotroski F-Score of 1/9, indicating severe financial weakness. The fund is trading at a significant premium to its growth-based intrinsic value of $5.25, with a current price of $10.86. A payout ratio of 152% suggests that the 10.50% dividend yield is unsustainable and likely funded by return of capital or leverage. Combined with a 0/100 technical trend, the asset presents as a high-risk value trap.
Compare Another Pair
Related Comparisons
BCBP vs HYI: Head-to-Head Comparison
This page compares BCB Bancorp, Inc. (BCBP) and Western Asset High Yield Opportunity Fund Inc. (HYI) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.